Androgen-Independent Prostatic Cancer
Oncology·MeSH: Anus Neoplasms
1 drug in development·1 company·2 clinical trials
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| Lorigerlimab | MACROGENICS INC (MGNX) |
Frequently asked questions
How many drugs are in development for Androgen-Independent Prostatic Cancer?
BioSniper tracks 1 drug in development for Androgen-Independent Prostatic Cancer across 1 company.
How many clinical trials target Androgen-Independent Prostatic Cancer?
There are 2 clinical trials targeting Androgen-Independent Prostatic Cancer tracked by BioSniper.
Deep-dive into Androgen-Independent Prostatic Cancer
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis